These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 33475046)

  • 1. Antimicrobial resistance control efforts in Africa: a survey of the role of Civil Society Organisations.
    Fraser JL; Alimi YH; Varma JK; Muraya T; Kujinga T; Carter VK; Schultsz C; Del Rio Vilas VJ
    Glob Health Action; 2021 Jan; 14(1):1868055. PubMed ID: 33475046
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential role of civil society organizations (CSOs) in antimicrobial resistance (AMR) mitigation efforts in low- and middle-income countries: A report from India.
    Ranganathan R; Ranjalkar J
    J Infect Public Health; 2023 Dec; 16 Suppl 1():125-128. PubMed ID: 37973495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing transparency and accountability of national action plans on antimicrobial resistance in 15 African countries.
    Harant A
    Antimicrob Resist Infect Control; 2022 Jan; 11(1):15. PubMed ID: 35073967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Civil society advocacy in Nigeria: promoting democratic norms or donor demands?
    Williamson RT; Rodd J
    BMC Int Health Hum Rights; 2016 Jul; 16(1):19. PubMed ID: 27400871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of national and international HIV/AIDS funding and governance mechanisms on the development of civil-society responses to HIV/AIDS in East and Southern Africa.
    Kelly KJ; Birdsall K
    AIDS Care; 2010; 22 Suppl 2():1580-7. PubMed ID: 21161762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Qualitative Study on the Design and Implementation of the National Action Plan on Antimicrobial Resistance in the Philippines.
    Lota MMM; Chua AQ; Azupardo K; Lumangaya C; Reyes KAV; Villanueva SYAM; Legido-Quigley H; Roxas EA
    Antibiotics (Basel); 2022 Jun; 11(6):. PubMed ID: 35740226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a cross-sectoral antimicrobial resistance capability assessment framework.
    Ferdinand AS; McEwan C; Lin C; Betham K; Kandan K; Tamolsaian G; Pugeva B; McKenzie J; Browning G; Gilkerson J; Coppo M; James R; Peel T; Levy S; Townell N; Jenney A; Stewardson A; Cameron D; Macintyre A; Buising K; Howden BP
    BMJ Glob Health; 2024 Jan; 9(1):. PubMed ID: 38232993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harm reduction in Europe: a framework for civil society-led monitoring.
    Rigoni R; Tammi T; van der Gouwe D; Schatz E
    Harm Reduct J; 2021 Jan; 18(1):3. PubMed ID: 33407566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The global governance of antimicrobial resistance: a cross-country study of alignment between the global action plan and national action plans.
    Munkholm L; Rubin O
    Global Health; 2020 Nov; 16(1):109. PubMed ID: 33176810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of civil society organizations in alcohol control during the COVID-19 pandemic across six countries in Africa.
    Aneja K; Diedericks AM; Halabi S; Gottschalk K; Waddell K; Tello JE
    Discov Soc Sci Health; 2023; 3(1):17. PubMed ID: 37547258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tackling antimicrobial resistance across sub-Saharan Africa: current challenges and implications for the future.
    Godman B; Egwuenu A; Wesangula E; Schellack N; Kalungia AC; Tiroyakgosi C; Kgatlwane J; Mwita JC; Patrick O; Niba LL; Amu AA; Oguntade RT; Alabi ME; Ncube NBQ; Sefah IA; Acolatse J; Incoom R; Guantai AN; Oluka M; Opanga S; Chikowe I; Khuluza F; Chiumia FK; Jana CE; Kalemeera F; Hango E; Fadare J; Ogunleye OO; Ebruke BE; Meyer JC; Massele A; Malande OO; Kibuule D; Kapona O; Zaranyika T; Bwakura-Dangarembizi M; Kujinga T; Saleem Z; Kurdi A; Shahwan M; Jairoun AA; Wale J; Brink AJ
    Expert Opin Drug Saf; 2022 Aug; 21(8):1089-1111. PubMed ID: 35876080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opportunities and challenges in antimicrobial resistance policy including animal production systems and humans across stakeholders in Argentina: a context and qualitative analysis.
    Allel K; Fernandez-Miyakawa M; Gaze W; Petroni A; Corso A; Luna F; Barcelona L; Boden L; Pitchforth E;
    BMJ Open; 2024 Jun; 14(6):e082156. PubMed ID: 38889938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How donors support civil society as government accountability advocates: a review of strategies and implications for transition of donor funding in global health.
    McDonough A; Rodríguez DC
    Global Health; 2020 Nov; 16(1):110. PubMed ID: 33183333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic diversity and risk factors for the transmission of antimicrobial resistance across human, animals and environmental compartments in East Africa: a review.
    Katale BZ; Misinzo G; Mshana SE; Chiyangi H; Campino S; Clark TG; Good L; Rweyemamu MM; Matee MI
    Antimicrob Resist Infect Control; 2020 Aug; 9(1):127. PubMed ID: 32762743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance of antimicrobial resistance in the United Arab Emirates: the early implementation phase.
    Thomsen J; Abdulrazzaq NM; AlRand H;
    Front Public Health; 2023; 11():1247627. PubMed ID: 38074700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementing national strategies on antimicrobial resistance in Thailand: potential challenges and solutions.
    Sommanustweechai A; Tangcharoensathien V; Malathum K; Sumpradit N; Kiatying-Angsulee N; Janejai N; Jaroenpoj S
    Public Health; 2018 Apr; 157():142-146. PubMed ID: 29524812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moving from assessments to implementation: promising practices for strengthening multisectoral antimicrobial resistance containment capacity.
    Joshi MP; Alombah F; Konduri N; Ndiaye A; Kusu N; Kiggundu R; Lusaya EP; Tuala Tuala R; Embrey M; Hafner T; Traore O; Mbaye M; Akinola B; Namburete D; Acho A; Hema Y; Getahun W; Sayem MA; Nfor E
    One Health Outlook; 2023 Apr; 5(1):7. PubMed ID: 37055845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From spectators to implementers: civil society organizations involved in AIDS programmes in China.
    Li H; Kuo NT; Liu H; Korhonen C; Pond E; Guo H; Smith L; Xue H; Sun J
    Int J Epidemiol; 2010 Dec; 39 Suppl 2(Suppl 2):ii65-71. PubMed ID: 21113039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impetus to Africa CDC's mandate in curbing the rising trend of Antimicrobial Resistance (AMR) in Africa: the launch of the Africa CDC AMR surveillance network during the 8th advanced course in diagnostics (ACDx).
    Takah NF; Shrestha P; Peeling R
    Pan Afr Med J; 2017; 28():271. PubMed ID: 29942410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Closing the GAP in Antimicrobial Resistance Policy in Benin and Burkina Faso.
    Sariola S; Butcher A; Cañada JA; Aïkpé M; Compaore A
    mSystems; 2022 Aug; 7(4):e0015022. PubMed ID: 35894597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.